X H. Wu-Xiaohua
270 Dong An Road
Shanghai, 200032, China
Shanghai, 200032, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 39 publications
Fruquintinib plus sintilimab in advanced cervical cancer: an open-label, multicentre, phase 2 study.
Fruquintinib plus sintilimab in advanced cervical cancer: an open-label, multicentre, phase 2 study.
Journal: Communications medicine
Published: September 18, 2025
Fruquintinib plus sintilimab in patients with advanced endometrial cancer with mismatch-repair proficient status: a multicenter, single-arm, phase Ib/II trial.
Journal: Nature communications
Published: May 19, 2025
Cadonilimab plus chemotherapy with or without bevacizumab as first-line treatment for advanced cervical cancer: subgroup analyses from the COMPASSION-16 phase 3 trial.
Journal: Nature communications
Published: April 21, 2025
Cadonilimab in advanced cervical cancer: the COMPASSION-16 trial - Authors' reply.
Journal: Lancet (London, England)
Published: April 14, 2025
YY1-induced USP43 drives ferroptosis suppression by FASN stabilization and subsequent activation of SLC7A11 in ovarian cancer.
Journal: Cell death & disease
Published: February 04, 2025
Epithelial characteristics of ovarian clear cell carcinoma at single-cell resolution.
Journal: Communications biology
Published: November 14, 2024
Genetic and therapeutic heterogeneity shape the baseline and longitudinal immune ecosystem of ovarian clear cell carcinoma.
Journal: Journal for immunotherapy of cancer
Published: November 06, 2024
Cadonilimab plus platinum-based chemotherapy with or without bevacizumab as first-line treatment for persistent, recurrent, or metastatic cervical cancer (COMPASSION-16): a randomised, double-blind, placebo-controlled phase 3 trial in China.
Journal: Lancet (London, England)
Published: August 28, 2024
Clinical significance of intensity-modulated radiotherapy (IMRT) to the distant metastatic lymph nodes for metastatic cervical cancer.
Journal: BMC cancer
Published: April 24, 2024
Last Updated: 09/26/2026